Skip to content

Comparison of the anesthetic effects of remazolam and dexmedetomidine in patients undergoing scoliosis surgery

Comparison of the anesthetic effects of remazolam and dexmedetomidine in patients undergoing scoliosis surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074834
Enrollment
Unknown
Registered
2023-08-17
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scoliosis

Interventions

Con group:The anesthesia induction scheme is Midazolam 2~4mg+sufentanil 0.3~0.4 µ g/kg+Etomidate 0.2 mg/kg+cisatracurium 0.15~0.20 mg/kg. Propofol 4-8mg/(kg · h)+remifentanil 0.1-0.3 µ g/(kg · min)+ci
Dex group:On the basis of the Con group, the Dex group was combined with dexmedetomidine hydrochloride, before anesthesia induction 0.5 µg/kg of dexmedetomidine hydrochloride was injected within 10 mi
Rem group:Rem group was combined with remazolam toluenesulfonate on the basis of the Con group. The drug was administered at a rate of 0.3 mg/kg during anesthesia induction and 1.0~2.0 mg/(kg · h) dur

Sponsors

Shifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients with lateral curvature of the spine greater than 10 ° according to X-ray examination and scheduled for scoliosis correction surgery; ? Normal cognitive and communication abilities, able to cooperate in completing relevant scale assessments; ? The American Association of Anesthesiologists (ASA) is classified as Level I-III; ? Body mass index (BMI) 18-28kg/m2.

Exclusion criteria

Exclusion criteria: ? Severe hypertension or diabetes; ? Coronary heart disease; ? Central nervous system disease; ? Difficult airway; ? Allergies to the study Drug allergy; ? Intermittent or long-term use of benzodiazepines or opioids within 2 months prior to admission.

Design outcomes

Primary

MeasureTime frame
Intraoperative arousal quality;VAS scores;

Secondary

MeasureTime frame
interleukin-10;interleukin-6;Tumor Necrosis Factor- a;PGE2;HMGB1;adrenaline;norepinephrine;cortisol;

Countries

China

Contacts

Public ContactLin Zeng

Shifang People's Hospital

343329636@qq.com+86 152 8147 0503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026